Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $34,894 | 6 | 99.9% |
| Food and Beverage | $52.36 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ocular Therapeutix, Inc. | $34,894 | 6 | $0 (2020) |
| BioDelivery Sciences International, Inc. | $52.36 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $34,894 | 6 | Ocular Therapeutix, Inc. ($34,894) |
| 2017 | $52.36 | 1 | BioDelivery Sciences International, Inc. ($52.36) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 10/31/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,187.50 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 09/30/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Consulting Fee | Cash or cash equivalent | $4,062.50 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 08/31/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Consulting Fee | Cash or cash equivalent | $5,781.25 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 07/31/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Consulting Fee | Cash or cash equivalent | $11,300.00 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 06/30/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Consulting Fee | Cash or cash equivalent | $9,062.50 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 09/05/2017 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $52.36 | General |
| Category: Addiction Therapy | ||||||
About Dr. Alan Dunton, M.D
Dr. Alan Dunton, M.D is a Internal Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841417359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Dunton, M.D has received a total of $34,946 in payments from pharmaceutical and medical device companies, with $34,894 received in 2020. These payments were reported across 7 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($34,894).
Practice Information
- Specialty Internal Medicine
- Location Staten Island, NY
- Active Since 04/19/2007
- Last Updated 04/17/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841417359
Products in Payments
- DEXTENZA (Drug) $34,894
- BELBUCA (Drug) $52.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Staten Island
Dr. Seth Brum, M.d, M.D
Internal Medicine — Payments: $409,260
Dr. Maryann Lee, M.d, M.D
Internal Medicine — Payments: $115,406
Dr. Alexander Beylinson, D.o, D.O
Internal Medicine — Payments: $61,903
Dr. Miguel Tirado, M.d, M.D
Internal Medicine — Payments: $35,111
Dr. John Zafaranloo, M.d, M.D
Internal Medicine — Payments: $29,178
Dr. Efat Azizi, M.d, M.D
Internal Medicine — Payments: $28,427